---
title: Caffeine + Paracetamol + Taurine + Tramadol
description: >-
  This combination is prescribed for the short-term (≤5 days) management of
  moderate to severe acute pain, such as back pain, where the pain is thought to
  require the combined effects of tramadol and paracetamol. It is indicated when
  single-agent therapy is insufficient.  This is not a standard, pr...
is_banned: false
lastModified: '2025-09-22T17:22:08.467Z'
faqs:
  - q: >-
      What is the recommended dosage for Caffeine + Paracetamol + Taurine +
      Tramadol?**


      A: Adults: Initial dose: Two tablets (37.5mg/325mg/30mg/250mg combination)
      or one tablet (75mg/650mg tramadol/paracetamol combination). Max 8 tablets
      (37.5mg/325mg) or 4 tablets (75mg/650mg) per day, every 6 hours. Children:
      Not recommended under 12.
    a: >-
      A: Adults: Initial dose: Two tablets (37.5mg/325mg/30mg/250mg combination)
      or one tablet (75mg/650mg tramadol/paracetamol combination). Max 8 tablets
      (37.5mg/325mg) or 4 tablets (75mg/650mg) per day, every 6 hours. Children:
      Not recommended under 12.
  - q: >-
      What are the primary contraindications for this combination?**


      A: Hypersensitivity, severe hepatic/renal impairment, respiratory
      depression, acute intoxication with CNS depressants, concurrent MAOI use,
      uncontrolled epilepsy.
    a: >-
      A: Hypersensitivity, severe hepatic/renal impairment, respiratory
      depression, acute intoxication with CNS depressants, concurrent MAOI use,
      uncontrolled epilepsy.
  - q: >-
      What are the key drug interactions to be aware of?**


      A: MAOIs, CNS depressants, serotonergic drugs, CYP450 inducers/inhibitors,
      anticoagulants, alcohol.
    a: >-
      A: MAOIs, CNS depressants, serotonergic drugs, CYP450 inducers/inhibitors,
      anticoagulants, alcohol.
  - q: >-
      Can this combination be used during pregnancy or breastfeeding?**


      A:  Avoid during pregnancy unless benefit clearly outweighs risk. Avoid
      during breastfeeding.
    a: >-
      A:  Avoid during pregnancy unless benefit clearly outweighs risk. Avoid
      during breastfeeding.
  - q: |-
      What are the most common side effects?**

      A: Nausea, vomiting, constipation, dizziness, drowsiness.
    a: 'A: Nausea, vomiting, constipation, dizziness, drowsiness.'
  - q: >-
      What serious side effects warrant immediate attention?**


      A: Respiratory depression, serotonin syndrome, seizures, severe allergic
      reactions, hepatotoxicity.
    a: >-
      A: Respiratory depression, serotonin syndrome, seizures, severe allergic
      reactions, hepatotoxicity.
  - q: >-
      What monitoring parameters are recommended during treatment?**


      A: Respiratory rate, pain level, mental status, and liver function (with
      prolonged use).
    a: >-
      A: Respiratory rate, pain level, mental status, and liver function (with
      prolonged use).
  - q: >-
      How does caffeine interact with this combination?**


      A: Caffeine is thought to potentiate the analgesic effect and may reduce
      some side effects like nausea.  It can also cause increased alertness and
      stimulation.
    a: >-
      A: Caffeine is thought to potentiate the analgesic effect and may reduce
      some side effects like nausea.  It can also cause increased alertness and
      stimulation.
  - q: >-
      What is the role of taurine in this combination?**


      A:  Taurine's role is not fully understood but is thought to contribute
      through possible antioxidant and neuromodulatory effects.
    a: >-
      A:  Taurine's role is not fully understood but is thought to contribute
      through possible antioxidant and neuromodulatory effects.
  - q: >-
      What precautions should be taken when prescribing this combination to
      elderly patients?**


      A: Dosage adjustments may be needed due to altered pharmacokinetics. 
      Monitor closely for adverse effects. Start at a lower dose and increase
      gradually as needed. Extend the dosing interval as needed due to
      potentially prolonged elimination.
    a: >-
      A: Dosage adjustments may be needed due to altered pharmacokinetics. 
      Monitor closely for adverse effects. Start at a lower dose and increase
      gradually as needed. Extend the dosing interval as needed due to
      potentially prolonged elimination.
---
## **Usage**

This combination is prescribed for the short-term (≤5 days) management of moderate to severe acute pain, such as back pain, where the pain is thought to require the combined effects of tramadol and paracetamol. It is indicated when single-agent therapy is insufficient.  This is not a standard, pre-approved, fixed-dose combination in many regions and should be used under strict medical supervision.

* **Pharmacological Classification:** Analgesic Combination (Opioid and Non-Opioid), Antipyretic.

* **Mechanism of Action:** This combination exerts analgesic effects through multiple mechanisms: opioid receptor binding (tramadol), central prostaglandin inhibition (paracetamol), and possible neuromodulation (taurine). Caffeine is thought to enhance the analgesic effects of the other components.


## **Alternate Names**

* Asque Tablet
* Paxin TC Tablet

## **How It Works**

* **Pharmacodynamics:** Tramadol binds to mu-opioid receptors and inhibits serotonin and norepinephrine reuptake. Paracetamol inhibits prostaglandin synthesis in the CNS. Caffeine enhances the analgesic effects of the other components and acts as a CNS stimulant. Taurine, an amino acid, might have a neuromodulatory effect, but its exact role is not well established.

* **Pharmacokinetics:**
    * **Absorption:** All components are readily absorbed orally.
    * **Metabolism:** Paracetamol and tramadol are metabolized primarily in the liver. Caffeine is metabolized by CYP1A2. Taurine has minimal metabolism.
    * **Elimination:** Metabolites are primarily excreted renally.

* **Mode of Action:** Tramadol binds to mu-opioid receptors, inhibiting pain signal transmission. Paracetamol reduces pain and fever by inhibiting prostaglandin synthesis. Caffeine increases alertness and potentiates the analgesic effects.  The overall effect aims for broader and more effective pain relief than any single component.

* **Receptor Binding/Enzyme Inhibition/Neurotransmitter Modulation:** Tramadol binds to mu-opioid receptors. Paracetamol inhibits prostaglandin synthesis. Tramadol inhibits the reuptake of serotonin and norepinephrine.

* **Elimination Pathways:** Primarily renal excretion of metabolites.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

Initial dose: Two tablets of Tramadol 37.5 mg/Paracetamol 325 mg/Caffeine 30 mg/Taurine 250 mg, or one tablet of a 75mg/650mg Tramadol/Paracetamol combination. Additional doses can be taken as needed, not exceeding 8 tablets of the 37.5mg/325mg combination (or equivalent) per day. The dosing interval should not be less than 6 hours. Treatment duration should not exceed 5 days.

#### **Children:**

Not recommended for children under 12 years old. Safety and effectiveness in this population have not been established.

#### **Special Cases:**

* **Elderly Patients (over 75 years):** Elimination may be prolonged. Dosage intervals should be extended as needed.

* **Patients with Renal Impairment:**
    * Moderate Impairment (CrCl 10-30 mL/min): Increase dosing interval to 12 hours.
    * Severe Impairment (CrCl <10 mL/min): Contraindicated.

* **Patients with Hepatic Dysfunction:**
    * Mild to Moderate Impairment: Use with caution; dosage adjustment may be necessary.
    * Severe Impairment: Contraindicated.

* **Patients with Comorbid Conditions:** Use with caution in cardiovascular disease, diabetes, seizure disorders, lung disease, head injuries, or history of opioid/alcohol dependence.

### **Clinical Use Cases**

This combination is not indicated for intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations.  Alternative pain management strategies are generally employed in these settings.

### **Dosage Adjustments**

Adjustments should be based on patient response, pain intensity, age, and organ function. Careful consideration is required for patients with renal or hepatic impairment.


## **Side Effects**

### **Common Side Effects:**

Nausea, vomiting, constipation, dry mouth, dizziness, somnolence, weakness, restlessness, increased heart rate.

### **Rare but Serious Side Effects:**

Seizures, allergic reactions (e.g., skin rash, itching, swelling), respiratory depression, serotonin syndrome (e.g., agitation, confusion, hallucinations, tachycardia, fever), hepatotoxicity.

### **Long-Term Effects:**

Tolerance and physical dependence with prolonged tramadol use. Potential for paracetamol-related liver damage with chronic overuse.

### **Adverse Drug Reactions (ADR):**

Anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema.


## **Contraindications**

Hypersensitivity to any component, severe hepatic impairment, severe respiratory depression, acute intoxication with alcohol, hypnotics, centrally acting analgesics, opioids, or psychotropic drugs, concurrent use of MAOIs or within two weeks of their discontinuation, epilepsy not controlled by treatment.


## **Drug Interactions**

MAOIs (risk of serotonin syndrome), CNS depressants (increased respiratory depression and sedation), serotonergic drugs (increased risk of serotonin syndrome), CYP2D6 inhibitors/inducers (affect tramadol metabolism), CYP3A4 and CYP1A2 inhibitors/inducers (affect caffeine metabolism), anticoagulants (tramadol may enhance effects), alcohol (increased risk of liver damage and sedation).


## **Pregnancy and Breastfeeding**

Tramadol and paracetamol cross the placenta.  Tramadol, especially in the third trimester, can cause neonatal opioid withdrawal syndrome. Avoid this combination during pregnancy unless benefits clearly outweigh risks. All components are excreted in breast milk, potentially causing neonatal adverse effects.  This combination should be avoided during breastfeeding.


## **Drug Profile Summary**

* **Mechanism of Action:** Tramadol: Mu-opioid agonist, serotonin/norepinephrine reuptake inhibitor. Paracetamol: Central prostaglandin inhibition. Caffeine: Analgesic adjuvant, CNS stimulant. Taurine: Possible neuromodulator.
* **Side Effects:** Nausea, vomiting, constipation, dizziness, somnolence; rarely, seizures, respiratory depression, serotonin syndrome, hepatotoxicity.
* **Contraindications:** Hypersensitivity, severe hepatic/renal impairment, respiratory depression, acute intoxication with CNS depressants, concurrent MAOI use, uncontrolled epilepsy.
* **Drug Interactions:** MAOIs, CNS depressants, serotonergic drugs, CYP2D6/3A4/1A2 inhibitors/inducers, anticoagulants, alcohol.
* **Pregnancy & Breastfeeding:**  Avoid unless benefit outweighs risk (pregnancy).  Avoid (breastfeeding).
* **Dosage:** Adults: Max 8 tablets (37.5mg/325mg) or 4 tablets (75mg/650mg) per day. Children: Not recommended under 12.
* **Monitoring Parameters:** Pain intensity, respiratory rate, mental status, liver function tests (with prolonged use).


## **Popular Combinations**

Not applicable, as this is already a combination product.


## **Precautions**

Assess renal and hepatic function. Monitor for respiratory depression and serotonin syndrome. Avoid alcohol and other CNS depressants. Use cautiously in elderly patients and those with comorbidities. Advise against driving/operating machinery until effects are known.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Caffeine + Paracetamol + Taurine + Tramadol?**

A: Adults: Initial dose: Two tablets (37.5mg/325mg/30mg/250mg combination) or one tablet (75mg/650mg tramadol/paracetamol combination). Max 8 tablets (37.5mg/325mg) or 4 tablets (75mg/650mg) per day, every 6 hours. Children: Not recommended under 12.


### **Q2: What are the primary contraindications for this combination?**

A: Hypersensitivity, severe hepatic/renal impairment, respiratory depression, acute intoxication with CNS depressants, concurrent MAOI use, uncontrolled epilepsy.


### **Q3:  What are the key drug interactions to be aware of?**

A: MAOIs, CNS depressants, serotonergic drugs, CYP450 inducers/inhibitors, anticoagulants, alcohol.


### **Q4: Can this combination be used during pregnancy or breastfeeding?**

A:  Avoid during pregnancy unless benefit clearly outweighs risk. Avoid during breastfeeding.


### **Q5:  What are the most common side effects?**

A: Nausea, vomiting, constipation, dizziness, drowsiness.


### **Q6: What serious side effects warrant immediate attention?**

A: Respiratory depression, serotonin syndrome, seizures, severe allergic reactions, hepatotoxicity.


### **Q7: What monitoring parameters are recommended during treatment?**

A: Respiratory rate, pain level, mental status, and liver function (with prolonged use).


### **Q8: How does caffeine interact with this combination?**

A: Caffeine is thought to potentiate the analgesic effect and may reduce some side effects like nausea.  It can also cause increased alertness and stimulation.

### **Q9: What is the role of taurine in this combination?**

A:  Taurine's role is not fully understood but is thought to contribute through possible antioxidant and neuromodulatory effects.



### **Q10: What precautions should be taken when prescribing this combination to elderly patients?**

A: Dosage adjustments may be needed due to altered pharmacokinetics.  Monitor closely for adverse effects. Start at a lower dose and increase gradually as needed. Extend the dosing interval as needed due to potentially prolonged elimination.



